Literature DB >> 31553908

HIV-1 Envelope Overcomes NLRP3-Mediated Inhibition of F-Actin Polymerization for Viral Entry.

Audrey Paoletti1, Awatef Allouch1, Marina Caillet2, Hela Saïdi3, Frédéric Subra4, Roberta Nardacci5, Qiuji Wu1, Zeinaf Muradova1, Laurent Voisin1, Syed Qasim Raza1, Frédéric Law1, Maxime Thoreau1, Haithem Dakhli1, Olivier Delelis4, Béatrice Poirier-Beaudouin3, Nathalie Dereuddre-Bosquet6, Roger Le Grand6, Olivier Lambotte7, Asier Saez-Cirion8, Gianfranco Pancino8, David M Ojcius9, Eric Solary10, Eric Deutsch11, Mauro Piacentini12, Marie-Lise Gougeon3, Guido Kroemer13, Jean-Luc Perfettini14.   

Abstract

Purinergic receptors and nucleotide-binding domain leucine-rich repeat containing (NLR) proteins have been shown to control viral infection. Here, we show that the NLR family member NLRP3 and the purinergic receptor P2Y2 constitutively interact and regulate susceptibility to HIV-1 infection. We found that NLRP3 acts as an inhibitory factor of viral entry that represses F-actin remodeling. The binding of the HIV-1 envelope to its host cell receptors (CD4, CXCR4, and/or CCR5) overcomes this restriction by stimulating P2Y2. Once activated, P2Y2 enhances its interaction with NLRP3 and stimulates the recruitment of the E3 ubiquitin ligase CBL to NLRP3, ultimately leading to NLRP3 degradation. NLRP3 degradation is permissive for PYK2 phosphorylation (PYK2Y402∗) and subsequent F-actin polymerization, which is required for the entry of HIV-1 into host cells. Taken together, our results uncover a mechanism by which HIV-1 overcomes NLRP3 restriction that appears essential for the accomplishment of the early steps of HIV-1 entry.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CBL; HIV; NLRP3; P2Y2; inflammasome; viral entry

Year:  2019        PMID: 31553908     DOI: 10.1016/j.celrep.2019.02.095

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  9 in total

Review 1.  The role of Pannexin-1 channels and extracellular ATP in the pathogenesis of the human immunodeficiency virus.

Authors:  Daniela D'Amico; Silvana Valdebenito; Eliseo A Eugenin
Journal:  Purinergic Signal       Date:  2021-09-20       Impact factor: 3.765

Review 2.  Immunometabolism and HIV-1 pathogenesis: food for thought.

Authors:  Asier Sáez-Cirión; Irini Sereti
Journal:  Nat Rev Immunol       Date:  2020-08-06       Impact factor: 53.106

Review 3.  Involvement of the Actin Machinery in Programmed Cell Death.

Authors:  Weida Ren; Wanyu Zhao; Lingbo Cao; Junqi Huang
Journal:  Front Cell Dev Biol       Date:  2021-02-09

Review 4.  From Entry to Egress: Strategic Exploitation of the Cellular Processes by HIV-1.

Authors:  Pavitra Ramdas; Amit Kumar Sahu; Tarun Mishra; Vipin Bhardwaj; Ajit Chande
Journal:  Front Microbiol       Date:  2020-12-04       Impact factor: 5.640

Review 5.  The Role of Inflammasome Activation in Early HIV Infection.

Authors:  Cyril Jabea Ekabe; Njinju Asaba Clinton; Jules Kehbila; Ngangom Chouamo Franck
Journal:  J Immunol Res       Date:  2021-09-20       Impact factor: 4.818

Review 6.  The Role of Pannexin-1 Channels in HIV and NeuroHIV Pathogenesis.

Authors:  Cristian A Hernandez; Eugenin Eliseo
Journal:  Cells       Date:  2022-07-20       Impact factor: 7.666

Review 7.  HIV-1 capsid exploitation of the host microtubule cytoskeleton during early infection.

Authors:  Mojgan H Naghavi
Journal:  Retrovirology       Date:  2021-07-06       Impact factor: 4.602

Review 8.  Purinergic Receptors: Elucidating the Role of these Immune Mediators in HIV-1 Fusion.

Authors:  Tracey L Freeman; Talia H Swartz
Journal:  Viruses       Date:  2020-03-07       Impact factor: 5.048

9.  Actin Contributes to the Hyperexpression of Baculovirus Polyhedrin (polh) and p10 as a Component of Transcription Initiation Complex (TIC).

Authors:  Nan Chen; Guanping Chen; Xiangshuo Kong; Xiaofeng Wu
Journal:  Viruses       Date:  2022-01-14       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.